Literature DB >> 15848205

Synthesis and antimalarial activity of sulfonamide chalcone derivatives.

José N Domínguez1, Caritza León, Juan Rodrigues, Neira Gamboa de Domínguez, Jiri Gut, Philip J Rosenthal.   

Abstract

A series of sulfonamide chalcone derivatives were synthesized and investigated for their abilities to inhibit beta-hematin formation in vitro and their activity against cultured Plasmodium falciparum parasites. Inhibition of beta-hematin formation was minimal in the aromatic ring of the chalcone moiety as it appeared for compounds 4b, 4d-f, and greatest with compounds 4g (IC50 0.48 microM) and 4k (IC50 0.50 microM) with a substitution of 3,4,5-trimethoxyl and 3-pyridinyl, respectively. In this study, the most active compound resulted 1[4'-N(2'',5''-dichlorophenyl) sulfonyl-amidephenyl]-3-(4-methylphenyl)-2-propen-1-one 4i, effective as antimalarial by the inhibition of cultured P. falciparum parasites (1 microM). These studies open up the novel possibility of development of sulfonamide derivatives as antimalarials that target beta-hematin formation and the inhibition of the development of cultured P. falciparum parasites, which should help delay the rapid onset of resistance to drugs acting at only a single site. Results with these assays suggest that chalcones exert their antimalarial activity via multiple mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848205     DOI: 10.1016/j.farmac.2005.01.005

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  15 in total

1.  1-Phenyl-3-(2,4,6-trimethoxy-phen-yl)prop-2-en-1-one.

Authors:  Jianzhang Wu; Li Zhang; Jing Wang; Shulin Yang; Xiaokun Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-23

2.  (E)-3-(3-Bromo-phen-yl)-1-(4-methyl-phenyl)prop-2-en-1-one.

Authors:  Hongqi Li; B K Sarojini; C G D Raj; L N Madhu; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-10-31

3.  Synthesis and Antibacterial and Antifungal Studies of Novel Nitrogen Containing Heterocycles from 5-Ethylpyridin-2-ethanol.

Authors:  N B Patel; H R Patel
Journal:  Indian J Pharm Sci       Date:  2010-09       Impact factor: 0.975

4.  Folic acid-sulfonamide conjugates as antibacterial agents: design, synthesis and molecular docking studies.

Authors:  Shabnam Shahzad; Muhammad Abdul Qadir; Mahmood Ahmed; Saghir Ahmad; Muhammad Jadoon Khan; Asad Gulzar; Muhammad Muddassar
Journal:  RSC Adv       Date:  2020-11-25       Impact factor: 4.036

5.  Room temperature synthesis and antibacterial activity of new sulfonamides containing n,n-diethyl-substituted amido moieties.

Authors:  Olayinka O Ajani; Oluwole B Familoni; Feipeng Wu; Johnbull O Echeme; Zheng Sujiang
Journal:  Int J Med Chem       Date:  2012-10-17

6.  Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action.

Authors:  Maribel Navarro; William Castro; Marilyn Madamet; Rémy Amalvict; Nicolas Benoit; Bruno Pradines
Journal:  Malar J       Date:  2014-12-03       Impact factor: 2.979

7.  Design and synthesis of new N-(5-trifluoromethyl)-1H-1,2,4-triazol-3-yl benzenesulfonamides as possible antimalarial prototypes.

Authors:  Nubia Boechat; Luiz C S Pinheiro; Osvaldo A Santos-Filho; Isabor C Silva
Journal:  Molecules       Date:  2011-09-20       Impact factor: 4.411

8.  Synthesis and biological activities on metal complexes of 2,5-diamino-1,3,4-thiadiazole derived from semicarbazide hydrochloride.

Authors:  Joshua A Obaleye; Johnson F Adediji; Matthew A Adebayo
Journal:  Molecules       Date:  2011-07-12       Impact factor: 4.411

9.  Antimalarial Activities of (Z)-2-(Nitroheteroarylmethylene)-3(2H)-Benzofuranone Derivatives: In Vitro and In Vivo Assessment and β-Hematin Formation Inhibition Activity.

Authors:  Latifeh Navidpour; Kelly Chibale; Somayeh Esmaeili; Azadeh Ghiaee; Narges Hadj-Esfandiari; Mahboubeh Irani; Sheyda Ahmadi Koulaei; Narguess Yassa
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

Review 10.  Malaria in South America: a drug discovery perspective.

Authors:  Luiza R Cruz; Thomas Spangenberg; Marcus V G Lacerda; Timothy N C Wells
Journal:  Malar J       Date:  2013-05-24       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.